Published date: 23 August 2017

This notice was replaced on 20 April 2018

This notice does not contain the most up-to-date information about this procurement. The most recent notice is:

Awarded contract (published 17 September 2018, last edited 5 January 2021)

Closed future opportunity - This means that a potential contract has passed its approach to market date. A buyer can choose to consider any supplier interest or convert this notice into an opportunity ready for live procurement.


Contract summary

Industry

  • Vaccines - 33651600

Location of contract

Any region

Value of contract

£0

Procurement reference

CM/PHV/16/5504

Published date

23 August 2017

Approach to market date

24 April 2018

Contract start date

1 June 2019

Contract end date

31 May 2021

Contract is suitable for SMEs?

No

Contract is suitable for VCSEs?

No

Description

Meningococcal vaccine to be centrally purchased for the adolescent immunisation programme, either Men C or Men ACWY dependent on policy at that time.

More information

Spend profile

This table displays the spend profile of the notice
Financial year Budget
2019/2020 £0

Attachments

Additional text

This future opportunity was originally published 5 February 2016 under the Commercial Medicines Unit as the contact organisation. The original notice has now been withdrawn and this new notice reflects the contact address as Department of Health.

About the buyer

Address

Department of Health
2nd Floor, Rutland House
Runcorn
WA7 2ES
England

Email

natalie.howell@dh.gsi.gov.uk